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Haemolytic uraemic syndrome (HUS) is a rare but life-threatening complication of Shiga toxin
(Stx)-producing Escherichia coli (STEC) infections, characterized by acute renal failure,
thrombocytopenia and haemolytic anaemia. Although the main infection route is the consumption
of contaminated food or water, person-to-person transmission has been suggested in several
situations. Moreover, epidemiological data indicate that the horizontal transmission of several
pathogens, including STEC, among individuals of the same species requires significantly lower
doses than those used in animal models infected with laboratory-cultured bacteria. Thus, the aim
of this study was to evaluate whether the passage of a clinically isolated STEC strain through the
gastrointestinal tract of mice affects its pathogenicity in mice. To test this, weaned mice were
orally inoculated by gavage with either an E. coli O157 : H7 isolate from an HUS patient, or the
same strain recovered from stools after one or two successive passages through the
gastrointestinal tract of the mice. We show that stool-recovered strains are able to induce a more
generalized and persistent colonization than the parent strain. Furthermore, a 104-fold-reduced
inoculum of the stool-recovered strains still causes gut colonization and mouse mortality, which
are not observed with the parent strain. These results indicate an increased pathogenicity in stool-
recovered strains that may be associated with an increased ability to colonize the mouse intestine.
INTRODUCTION
Haemolytic uraemic syndrome (HUS) is characterized by
the triad microangiopathic haemolytic anaemia, thrombo-
cytopenia and nephropathy (Gianantonio et al., 1973). Shiga
toxin (Stx)-producing Escherichia coli (STEC) O157 : H7 has
been recognized as the most frequent serotype associated
with large outbreaks or sporadic cases of haemorrhagic
colitis and HUS in many countries (Griffin & Tauxe, 1991).
Although the main virulence factor of STEC is the
production of one or more types of Stx (Stx1, Stx2 or their
variants), adherence to the intestinal epithelium and gut
colonization are also important components of the patho-
genesis. Moreover, the degree of gut adhesion has been
correlated with the ability to cause disease (Frankel et al.,
1998; Turner et al., 2006). In humans, STEC infection and
HUS usually occur after the consumption of contaminated
food or water, having a minimal infective dose of ,10
bacteria per gram of food (Paton et al., 1996). Several
attempts have been made to develop reliable animal models
of STEC infection and HUS pathogenesis. However, in order
to establish infection, the use of very large doses of viable
micro-organisms is needed since STEC strains are poorly
pathogenic in other animal species. Furthermore, some HUS
animal models rely on the manipulation of the intestinal
environment with different drugs such as antibiotics
(Lindgren et al., 1993; Wadolkowski et al., 1990) or
mitomycin C (Fujii et al., 1994) in order to establish
reproducible infections. However, these treatments could
disturb the immune response of the host (Domingo et al.,
1995), alter Stx excretion (Grif et al., 1998) or induce
microangiopathy (Molyneux et al., 2005).
Abbreviations: HUS, haemolytic uraemic syndrome; STEC, Shiga toxin-
producing Escherichia coli; Stx, Shiga toxin.
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On the other hand, epidemiological data on several infectious
agents indicate that horizontal transmission among animals
of the same species requires significantly lower infective doses
than those used in animal models (Merrell et al., 2002; Wiles
et al., 2005). In this regard, previous reports have demon-
strated that calves have a high prevalence of natural infection
when they are exposed to low doses of E. coli O157 : H7
within a herd (Besser et al., 2001; Cray & Moon, 1995; Garber
et al., 1995; Hancock et al., 1997). Similarly, donor pigs that
shed very low levels of E. coli O157 : H7 in their faeces are
demonstrated to transmit these bacteria to naı̈ve pigs that
shared the same herd (Cornick & Helgerson, 2004). This
effect has also been reported in the natural transmission of
Salmonella Typhimurium (Fedorka-Cray et al., 1994) and
Salmonella Choleraesuis (Gray et al., 1996) in swine, and
Citrobacter rodentium in mice (Wiles et al., 2005), after
exposure to low levels of bacteria in the environment.
Although this fact has not yet been fully explained, it
probably reflects the importance of bacterial–host interaction
in the infection establishment by inducing bacterial patho-
genicity or in the maintenance of an animal reservoir.
Additionally, person-to-person transmission in HUS cases
has been proposed in several circumstances (Bell et al., 1994;
Crump et al., 2002; Karmali, 1989). Thus, the aim of this
study was to evaluate whether the passage of a human-
isolated STEC strain through the gastrointestinal tract of the
mouse affects its pathogenicity in mice.
We have previously developed an HUS mouse model in
weaned BALB/c mouse by oral administration of an E. coli
O157 : H7 isolate from an HUS patient (Brando et al., 2008).
In that work we found that the bacterial administration by
gavage causes a transient intestinal colonization and
symptoms of Stx2-mediated systemic toxicity in a percent-
age of the inoculated mice. Herein, we studied the influence
of successive passages through the gastrointestinal tract of
the mouse on the pathogenicity of STEC strains by using the
same HUS mouse model. We demonstrate that stool-
recovered strains are able to generate a more generalized and
persistent colonization than the parent strain. Furthermore,
we show that the use of a significantly lower inoculum of the
stool-recovered strains (104-fold-reduced) still results in gut
colonization and mouse mortality. These results suggest that
stool-recovered strains have a higher pathogenic capacity
even though Stx2 production was not increased.
Our results highlight the importance of bacterial adapta-
tion to the host gut environment for the colonization
process and the establishment of STEC infections.
Although the molecular mechanisms involved in these
processes remain to be elucidated, our experimental model
represents a new approach for using animal models to
study STEC infections.
METHODS
Mice and oral infection. Immature male and female BALB/c mice
were used immediately after weaning (17–20 days of age, ~8–11 g of
body weight). BALB/c mice were bred in the animal facility at the
Department of Experimental Medicine, Academia Nacional de
Medicina, Buenos Aires. Experiments performed herein were
approved by the Academia Nacional de Medicina Animal Care
Committee. Weaned mice were divided randomly into experimental
groups. After 8 h of starvation (Fernandez et al., 2003; Nagano et al.,
2003), animals were intragastrically inoculated via a stainless steel
canula (model 7.7.1, 0.38 mm x 22G) (Harvard Apparatus) with
0.1 ml of the corresponding bacterial suspension. Four hours after the
ingestion of the bacterial suspension, food and water were provided to
mice ad libitum. Animals were observed daily for activity level and
water intake for up to 10 days, when survivors were euthanized.
Blood and stool samples were examined at 48, 72 and 96 h after
infection.
Bacterial strains. Bacterial strains used in this study included a
strain isolated from a faecal specimen of a child with HUS (125/99),
(previously characterized in Brando et al., 2008) and two strains
recovered from faecal samples of inoculated mice (125r and 125rr),
which were obtained as follows: mice at weaning were intragastrically
inoculated with a total inoculum of the 125/99 strain (parent strain)
at a dose of 66109 c.f.u. kg21. Forty eight hours later, stool samples
were obtained and cultured onto Sorbitol MacConkey agar plates.
One non-sorbitol-fermenting colony was isolated and characterized
by the presence of stx2/rfbO157 with a multiplex PCR (Leotta et al.,
2005) and serotyped with somatic and flagellar antisera from the
Instituto Nacional de Producción de Biológicos- ANLIS ‘Dr Carlos G.
Malbrán’ (Orskov & Orskov, 1984). The reference E. coli strains
EDL933 O157 : H7 (stx1 and stx2), and ATCC 25922 were used as
positive and negative controls of gene expression, respectively. This
strain was named 125r, and after culturing in tryptic soy broth (TSB;
Difco), it was intragastrically inoculated into weaned mice at a dose of
26108 c.f.u. kg21. One non-sorbitol fermenting colony was isolated
from stools of inoculated mice and characterized by PCR and
serotyped as described previously. This strain, isolated from mouse
stools after two consecutive passages through the gastrointestinal tract
of a mouse, was named 125rr and, after culturing in TSB, was
intragastrically inoculated in weaned mice at a dose of 26108 c.f.u.
kg21. Both strains, the 125r and 125rr, were collectively named stool-
recovered strains, and were maintained at 270 uC in TSB
supplemented with 20 % (v/v) glycerol.
Bacterial growth. Bacterial culture was performed as described
previously (Brando et al., 2008). Briefly, strains were cultured
overnight at 37 uC in TSB. A 250 ml volume of each strain was
inoculated into five Erlenmeyer flasks (125 ml) containing 25 ml TSB
and incubated at 37 uC for 18 h. Cultures were centrifuged and
bacterial pellets were washed twice in PBS (pH 7.2; 0.01 M) and then
resuspended in 1 ml of PBS. Aliquots were diluted (102–104), plated
onto Plate Count Agar, and incubated overnight at 37 uC. Then,
c.f.u. ml21 was determined. Overnight cultures reached a final
concentration of 161010–1.861010 c.f.u. ml21.
Pulsed-field gel electrophoresis (PFGE). Macrorestriction frag-
ments analysis by PFGE was performed using the 24 h PulseNet
standardized PFGE protocol for E. coli O157 : H7 (Ribot et al., 2006).
The PulseNet strain used as a size standard was Salmonella
Braenderup H9812 (kindly provided by the Center for Disease
Control, Atlanta, GA, USA). Restriction digestion of DNA was carried
out with XbaI enzyme (Promega). PFGE images of gels were obtained
by Doc-It 2000 (Bio-Rad). Analysis of TIFF images was carried out
through the BioNumerics version 4.61 software package (Applied
Maths) by using the Dice coefficient and the unweighted pair group
method with arithmetic mean (UPGMA) to generate dendrograms
with 1.5 % tolerance values. Clusters were visually confirmed.
In vitro quantification of Shiga toxin production. Bacterial
supernatants of each strain were tested for Stx2 production by a
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standardized ELISA method according to manufacturer’s indications
(Ridascreen Verotoxin, R-Biopharm AG). In order to quantify the
Stx2, a standard curve was performed using serial dilutions of purified
Stx2 (Phoenix Lab, Tufts Medical Center, Boston, MA, USA). Then,
absorbance values of each strain were interpolated into the dose–
response curve and the Stx2 concentration was determined. The total
Stx2 production was calculated as the toxin released in the culture
supernatant plus the fraction stored in the periplasmic compartment
and released into the supernatant after polymixin B treatment
(Karmali, 1989; Karmali et al., 1985). Each bacterial supernatant was
evaluated in duplicate in two independent cultures.
Colonization: isolation and enumeration of STEC strains from
mouse intestine. Mice were killed at 72 and 96 h after bacterial
inoculation to determine intestinal colonization. Small and large
intestines were excised and stools were removed and diluted to 0.1 g
ml21. Each part of the intestine (5 cm each) was washed three times
vigorously with 6 ml of PBS by using biopsy forceps. Then, each
intestinal section was homogenized in 0.5 ml PBS. Viable counts were
performed by plating 100 ml stool samples or homogenized intestinal
tissues onto SMAC agar and incubating overnight at 37 uC. Non-
sorbitol-fermenting colonies were counted and selected at random for
confirmation by serotyping and multiplex PCR as described
previously. The number of c.f.u. per intestinal section was calculated
by considering the c.f.u. ml21 and the total volume of each sample.
Haematological studies. Blood samples were obtained by punc-
turing the retroorbital plexus at 48, 72 and 96 h after bacterial feeding
for laboratory analyses that included total and differential blood cell
counts in a Neubauer chamber, blood smears and blood urea nitrogen
determination. Biochemical determination of urea content in mouse
plasma was performed in an autoanalyser CCX spectrum (Abbot
Diagnostics Systems), following standardized instructions. Values
higher than the mean±2 SD of age-matched normal mice were
considered as increased.
Statistics. Survival data were analysed for significance by using log-
rank tests. Data expressed as the mean± SEM of individual mice were
analysed for statistical differences by using one- or two-way analysis
of variance (ANOVA). Comparisons, a posteriori, between two groups
were performed using the Student–Newman–Keuls (SNK) test.
Median values were compared using the Wilcoxon Signed Rank test.
RESULTS
Subtyping of bacterial strains
In order to characterize and establish the identity of the
stool-recovered strains with the parent strain, the macro-
restriction patterns of the DNA fragments generated by the
XbaI enzyme were compared as described in Methods. Fig.
1 shows that the XbaI-PFGE profiles from the three strains
were indistinguishable, thus indicating that the stool-
recovered strains had the same clonal origin as the parent
strain. We also confirmed that all strains had the same
serotype (O157 : H7) and genotype (eae/ehxA/stx2) deter-
mined as described in Methods. However, Stx2 production
was significantly decreased in both stool-recovered strains
compared to the parent strain as quantified by an ELISA
[mean Stx2 production±SEM (mg Stx2 ml21)]5125/99,
491±102; 125r, 298±63; 125rr, 274±22; two-way
ANOVA P,0.001. Similar results were obtained in the
evaluation of Stx2 biological activity on VERO cell cultures
(data not shown).
Effect of strain inoculation on mouse survival
Since mortality within 24 h post-inoculation was consid-
ered to be caused by endotoxic shock, the bacterial dose
was adjusted to minimize early deaths. Thus, 26108 c.f.u.
kg21 each strain was administered by gavage to BALB/c
mice at weaning. Mice were observed daily, and blood and
stool samples were collected until death. Differences were
not observed in the survival rates at this bacterial dose in
spite of the lower Stx2 production by the stool-recovered
strains (Fig. 2).
Clinical evaluation of infected mice
To assess the systemic effect of bacterial infection, blood
samples were obtained daily. Plasmatic urea levels (Fig. 3a)
and total (Fig. 3b) and differential (Fig. 3c) leukocyte
counts were evaluated. Data were retrospectively analysed
according to the final outcome of the inoculated mice.
Mice that died showed increased urea levels compared to
the survivors at 72 h after inoculation (Fig. 3a). On the
Fig. 1. XbaI profile of the studied strains. Dendrograms were
obtained with 1.5 % of tolerance and compared by the DICE
coefficient as described in Methods. The XbaI-PFGE pattern
obtained for the different strains was the same (AREXHX01-
0011).
Fig. 2. Survival rates of mice after bacterial inoculation. 17–
19 day-old mice were orally inoculated with 2108 c.f.u. kg”1 of
the indicated STEC strain (&, 125/99; X, 125r; and m, 125rr).
Survival of mice was monitored every 6 h after bacterial
inoculation. Survival percentages corresponding to at least four
pooled experiments with at least five mice per group are shown
(n520–63 mice by bacterial strain).
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other hand, only those mice that died after the inoculation
of stool-recovered strains showed a significant increase in
the percentage of circulating neutrophils (Fig. 3c) with a
significant decrease in total circulating leukocytes (Fig. 3b)
since 48 h after bacterial administration. Survivor mice
from all experimental groups showed leukocyte counts
similar to the control group.
Colonization of intestinal epithelium
The number of bacteria shed in stools (Fig. 4a and Table 1)
and adhered to small and large intestines (Fig. 4b and Table
1) was quantified at 72 and 96 h after inoculation. All
samples with 200 c.f.u. g21 faeces or more were considered
positive. The group of mice inoculated with stool-
Fig. 3. Clinical parameters in inoculated mice. Mean±SEM of
plasmatic urea values corresponding to at least four pooled
experiments with 4–36 mice per group is shown. Mice were
classified retrospectively in two groups according to their final
outcome (survivors or deceased). Data were compared by ANOVA
multiple comparison test and a posteriori by SNK test. (a)
Plasmatic urea levels at 72 h after bacterial inoculation. ANOVA,
**P,0.0001; SNK, P,0.0001 compared with survivors. (b, c)
Peripheral white cell counts after bacterial inoculation. Mice were
bled at 48, 72 and 96 h after oral inoculation (broken lines
represent survivors and solid lines represent deceased). (b) Total
leukocyte counts. ANOVA, *P,0.05; 72 h SNK, P,0.05;
strains125r and 125rr deceased compared to survivors. (c)
Percentage of neutrophils. ANOVA, ***P,0.0001; 48 h SNK,
P,0.05; strains125r deceased compared to 125/99 deceased
and survivors and 125rr deceased compared to 125/99 and 125rr
survivors; 72 h SNK, P,0.001 125r deceased compared to
survivors P,0.05 125rr deceased compared to 125r deceased
and 125/99 and 125r survivors.
Fig. 4. Bacterial isolation from stools (a) and small and large
intestine (b) from inoculated mice. Mice were euthanized at 72 and
96 h after intragastric inoculation of 125/99 (&), 125r (X) and
125rr (m) bacterial strains and the number of sorbitol-negative
c.f.u. was determined in stools (72 and 96 h) and intestines (72 h)
as described in Methods. Each symbol represents an individual
mouse from four pooled experiments and solid lines represent
median values. The detection limit in stools was 200 c.f.u. g”1 and
in small and large intestine was 1 c.f.u. cm”1. (a) **P,0.01
compared to 125/99 at the same time (b) *P,0.05 compared to
125/99.
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recovered strains had a significantly higher ratio of mice
with positive isolates and higher numbers of c.f.u. g21 in
faeces samples than the group of mice inoculated with the
parent strain (Fig. 4a and Table 1). In addition, the group
of mice inoculated with the 125rr strain showed a higher
ratio of STEC-positive isolates from the large intestine as
well as a higher number of c.f.u. recovered from both
intestinal segments than the parent strain at 72 h (Fig. 4b
and Table 1). On the other hand, the parent strain was
scarcely recovered from small intestine. These results
demonstrate that stool-recovered strains were able to
generate a more generalized and persistent colonization
in the intestine of weaned mice than the parent strain.
Additionally, the 125rr strain showed the highest adherence
to both intestinal segments. To confirm that counted
colonies were indeed STEC, randomly selected non-
sorbitol-fermenting colonies were examined for the
presence of stx1, stx2 and rfbO157 genes by multiplex
PCR. All tested colonies were positive for rfbO157 and stx2
genes (data not shown).
Macroscopic examination of the intestine of
inoculated mice
In order to establish whether the more generalized colo-
nization observed in the animals inoculated with the stool-
recovered strains leads to the development of differential
histological alterations, intestines of mice were examined
macroscopically. Fig. 5 shows a representative animal from
each experimental group. Although small intestines from
animals inoculated with all bacterial strains showed macro-
scopic alterations, those from animals inoculated with stool-
recovered strains showed the most widely distributed range
of alterations, i.e. they were sticky, considerably empty,
flimsy, breakable, and noticeably irrigated. On the other
hand, the distal colon from animals inoculated with the
parent strain contained formed stool pellets, whereas the
proximal colon contained semisolid stools. In contrast, large
intestines from animals inoculated with stool-recovered
strains were devoid of content and noticeably irrigated.
Pathogenicity at suboptimal inocula
To study whether the higher ability of the stool-recovered
strains to colonize the gut leads to an increased
pathogenicity in mice, several lower doses of the parent
or 125rr strains were intragastrically administered to mice
at weaning. The number of c.f.u. g21 of faeces at 72 h after
inoculation and the survival rate were evaluated. Mice
inoculated with 125rr strain at doses of 107, 106, 105 and
even 104 c.f.u. kg21 showed shedding of bacteria in faeces
at 72 h (Fig. 6). This strain was also able to induce 46 and
14 % mortality at doses of 16107 and 16104 c.f.u. kg21,
respectively (data not shown). In contrast, the parent strain
was scarcely isolated from faeces and did not induce death
in mice inoculated with these dosages.
Table 1. Bacterial isolation from faeces and intestinal tissues at 72 h after inoculation
Rank, number of c.f.u. isolated in positive samples; Ratio, no. of mice with at least one STEC-positive culture/total no. of mice evaluated; %,
percentage of mice with positive samples.








125/99 36101 66102–26105 5/15 33 3–4 2/14 14 0 0/14 0
125r 16104* 36102–861010 10/13 77D 46101–16104 2/13 15 5–16102 2/13 15
125rr 86106* 46102–261011 11/14 79D 16101–16106 5/14 36 1–46105 6/14 43D
*P,0.001 compared to 125/99





Fig. 5. Macroscopic examination of the intestines. Whole
intestines from mice inoculated with PBS, the parent STEC strain
(125/99) and stool-recovered STEC strains (125r and 125rr) at
72 h. One representative intestine of each group is shown.
Pictures were taken with a Nikon Coolpix 4500 digital camera.
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DISCUSSION
One of the difficulties encountered in the establishment of
a mouse model of HUS by gastric infection is the fact that
STEC strains are not pathogenic in mice. Thus, the
development of a reliable and reproducible HUS model
requires large infective doses. In this study, we show that a
human-isolated STEC strain is able to generate a more
generalized and persistent colonization of the mouse
intestine after the passage through the gastrointestinal
tract of the same species, thus providing a useful tool to
investigate colonization and pathology in mice.
Stool-recovered strains showed both faecal shedding and
an adherence to intestinal tissue that was significantly
increased compared to the parent strain when inoculated
into weaned mice. Moreover, the group of mice inoculated
with the 125rr strain, which had two successive passages
through the gastrointestinal tract of mice, exhibited the
highest ratio of mice with STEC-positive isolates from the
large intestine and the highest number of c.f.u. per gram of
faeces and per centimetre of tissue. These findings suggest
that stool-recovered strains display additional advantages
in the colonization process. It has been suggested that once
pathogens adhere to and colonize the intestinal epithelia,
they sense microenvironmental conditions such as tem-
perature, nutrient availability and presence of stress
hormones, thus adjusting their transcriptome/proteome
accordingly (Sperandio et al., 2003). Moreover, the study
of the transcriptional profile of bacteria directly isolated
from faeces revealed a unique behaviour characterized by
the high expression of genes required for nutrient
acquisition and motility (Merrell et al., 2002). In a similar
way, a uropathogenic E. coli strain isolated from the urine
of experimentally infected mice showed upregulation of
genes encoding adherence factors, drug resistance proteins,
antimicrobial peptides and proteins involved in iron
acquisition systems and the uptake and catabolism of
different sources of carbon (Snyder et al., 2004). In our
model, even though stool-recovered strains were grown in
TSB after isolation and before mouse administration, they
still showed an increased ability to colonize the mouse
intestine. Also, a second successive passage through the
gastrointestinal tract of mice further increased their ability
to colonize the mouse intestine.
Intestines from mice inoculated with stool-recovered
strains revealed larger macroscopic alterations than those
from mice fed with the parent strain. They appeared
particularly sticky, considerably empty, flimsy, breakable
and noticeably irrigated. In addition, stool-recovered
strains showed a differential colonization pattern, since
they were isolated from the large intestine of inoculated
mice. Previous reports have demonstrated that the
horizontal transmission of certain bacteria among animals
of the same species changes the infection pattern in
comparison to that observed in experimental infections
(Besser et al., 2001; Dekker et al., 1995; Gray et al., 1996;
Linton et al., 1985; Proux et al., 2001; Shere et al., 2002;
Yoshimatsu et al., 2000). It has been suggested that these
bacteria are already adapted to the host intestinal
environment, thus being able to colonize other sites
directly that they could not colonize otherwise (Wiles et
al., 2005). In the present work, although bacteria were not
directly transmitted among mice, they still showed a
differential colonization pattern. This probably indicates an
adaptation to the murine gut environment. Besides, a more
generalized and persistent intestinal colonization could
imply a greater disruption of the epithelial barrier, thus
facilitating the passage of Stx to systemic circulation. The
molecular basis that explains this differential pattern of
colonization should be studied further.
The analysis of the XbaI restriction patterns proved the
clonal relationship between the stool-recovered strains and
the parent strain. Also, the serotype and the genotype were
verified and their identity confirmed. However, stool-
recovered strains showed a decrease in Stx2 production
compared to the parent strain. Stx2 is encoded in a
lambdoid prophage, under the control of phage promoters
that modulate the lytic cycle (Mühldorfer et al., 1996).
Therefore, the production of Stx is significantly enhanced
when the phage is induced by several stress signals, such as
antibiotic exposure (Grif et al., 1998), norepinephrine
(Lyte et al., 1996), and hydrogen peroxide or neutrophils as
a consequence of activating the bacterial SOS response to
DNA damage (Wagner et al., 2001a). In addition, Stx2
expression is under the control of an antiterminator, which
acts as a transcriptional activator, and it has been
demonstrated that its over expression results in increased
Stx production (Neely & Friedman, 1998). Several reports
have examined the relationship between antiterminator
expression and Stx production. In fact, it has been
Fig. 6. Bacterial isolation from faeces after suboptimal inocula.
Mice were euthanized at 72 h after intragastric inoculation of 125/
99 (&) and 125rr (m) bacterial strains and the number of sorbitol-
negative c.f.u. was determined in stools as described in Methods.
Each symbol represents an individual mouse from two pooled
experiments and solid lines represent the median values.
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demonstrated that mutations in this antiterminator region
are responsible for decreased or even null Stx expression
(Koitabashi et al., 2006; Wagner et al., 2001b; Zhang et al.,
2010). Besides, it has been postulated that the SOS response
could regulate and co-ordinate the expression of Stx and
type III secretion (T3S) systems (Garmendia et al., 2005) to
potentiate colonization (Tree et al., 2009). Therefore, one of
these regulatory mechanisms could have been affected
during the passage through the gastrointestinal tract of
mice in our model, thus explaining the increased patho-
genicity observed in stool-recovered strains in spite of the
lower Stx2 production. In addition, the mentioned decrease
could explain the fact that stool-recovered strains adminis-
tered at optimal doses did not cause an increased mortality
in mice. On the other hand, it has been demonstrated that
the Stx cytotoxicity is increased by LPS in vivo (Keepers et
al., 2006; Palermo et al., 2000; Sauter et al., 2008). In
addition, an increased resistance to unfavourable host
intestinal environment has been related to an upregulation
of genes involved in LPS biosynthesis and its transport to the
cell surface (Snyder et al., 2004). However, it is unlikely that
a mechanism involved in LPS synthesis may account for the
differences observed among bacterial strains in our model
because stool-recovered strains did not show an increased
LPS content per cell compared to the parent strain (data not
shown). Further research will be necessary to completely
elucidate the underlying mechanism (genetic or epigenetic)
involved in the pathogenesis and the bacterial adaptation to
the murine intestinal environment.
Finally, our results show that stool-recovered strains are
able to persist, multiply and colonize the intestinal
microenvironment when significantly lower inocula were
used. Moreover, the use of a 104-fold-reduced inoculum
was still able to induce death in a percentage of mice, in
spite of the lower Stx2 production. These results suggest
that bacteria adapted to the host intestinal environment
may have a lower infective dose, thus facilitating intestinal
colonization and environmental dissemination. Taken
together, our findings in the HUS mouse model provide
evidence for the adaptation of a human STEC strain to the
mouse intestine, thus representing a useful tool for the
investigation of STEC pathogenesis.
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The authors thank Héctor Costa and Antonio Morales for their
excellent technical assistance. This work was supported by grants
from Alberto J. Roemmers Foundation, CONICET and Agencia
Nacional de Promoción Cientı́fica y Tecnológica, Argentina.
REFERENCES
Bell, B. P., Goldoft, M., Griffin, P. M., Davis, M. A., Gordon, D. C., Tarr,
P. I., Bartleson, C. A., Lewis, J. H., Barrett, T. J. & other authors
(1994). A multistate outbreak of Escherichia coli O157 : H7-associated
bloody diarrhea and hemolytic uremic syndrome from hamburgers.
The Washington experience. JAMA 272, 1349–1353.
Besser, T. E., Richards, B. L., Rice, D. H. & Hancock, D. D. (2001).
Escherichia coli O157 : H7 infection of calves: infectious dose and
direct contact transmission. Epidemiol Infect 127, 555–560.
Brando, R. J., Miliwebsky, E., Bentancor, L., Deza, N., Baschkier, A.,
Ramos, M. V., Fernández, G. C., Meiss, R., Rivas, M. & Palermo, M. S.
(2008). Renal damage and death in weaned mice after oral infection
with Shiga toxin 2-producing Escherichia coli strains. Clin Exp
Immunol 153, 297–306.
Cornick, N. A. & Helgerson, A. F. (2004). Transmission and infectious
dose of Escherichia coli O157 : H7 in swine. Appl Environ Microbiol 70,
5331–5335.
Cray, W. C., Jr & Moon, H. W. (1995). Experimental infection of calves
and adult cattle with Escherichia coli O157 : H7. Appl Environ
Microbiol 61, 1586–1590.
Crump, J. A., Sulka, A. C., Langer, A. J., Schaben, C., Crielly, A. S.,
Gage, R., Baysinger, M., Moll, M., Withers, G. & other authors (2002).
An outbreak of Escherichia coli O157 : H7 infections among visitors to
a dairy farm. N Engl J Med 347, 555–560.
Dekker, A., Moonen, P., de Boer-Luijtze, E. A. & Terpstra, C. (1995).
Pathogenesis of swine vesicular disease after exposure of pigs to an
infected environment. Vet Microbiol 45, 243–250.
Domingo, S., Dı́az, R. & Gamazo, C. (1995). Antibiotic treatment
induces an increase of the specific antibody levels in Brucella
melitensis infected mice. FEMS Immunol Med Microbiol 12, 91–95.
Fedorka-Cray, P. J., Whipp, S. C., Isaacson, R. E., Nord, N. & Lager, K.
(1994). Transmission of Salmonella Typhimurium to swine. Vet
Microbiol 41, 333–344.
Fernandez, M. I., Thuizat, A., Pedron, T., Neutra, M., Phalipon, A. &
Sansonetti, P. J. (2003). A newborn mouse model for the study of
intestinal pathogenesis of shigellosis. Cell Microbiol 5, 481–491.
Frankel, G., Phillips, A. D., Rosenshine, I., Dougan, G., Kaper, J. B. &
Knutton, S. (1998). Enteropathogenic and enterohaemorrhagic
Escherichia coli: more subversive elements. Mol Microbiol 30, 911–921.
Fujii, J., Kita, T., Yoshida, S., Takeda, T., Kobayashi, H., Tanaka, N.,
Ohsato, K. & Mizuguchi, Y. (1994). Direct evidence of neuron
impairment by oral infection with verotoxin-producing Escherichia
coli O157 : H- in mitomycin-treated mice. Infect Immun 62, 3447–
3453.
Garber, L. P., Wells, S. J., Hancock, D. D., Doyle, M. P., Tuttle, J., Shere,
J. A. & Zhao, T. (1995). Risk factors for fecal shedding of Escherichia coli
O157 : H7 in dairy calves. J Am Vet Med Assoc 207, 46–49.
Garmendia, J., Frankel, G. & Crepin, V. F. (2005). Enteropathogenic
and enterohemorrhagic Escherichia coli infections: translocation,
translocation, translocation. Infect Immun 73, 2573–2585.
Gianantonio, C. A., Vitacco, M., Mendilaharzu, F., Gallo, G. E. & Sojo,
E. T. (1973). The hemolytic-uremic syndrome. Nephron 11, 174–192.
Gray, J. T., Fedorka-Cray, P. J., Stabel, T. J. & Kramer, T. T. (1996).
Natural transmission of Salmonella Choleraesuis in swine. Appl
Environ Microbiol 62, 141–146.
Grif, K., Dierich, M. P., Karch, H. & Allerberger, F. (1998). Strain-
specific differences in the amount of Shiga toxin released from
enterohemorrhagic Escherichia coli O157 following exposure to
subinhibitory concentrations of antimicrobial agents. Eur J Clin
Microbiol Infect Dis 17, 761–766.
Griffin, P. M. & Tauxe, R. V. (1991). The epidemiology of infections
caused by Escherichia coli O157 : H7, other enterohemorrhagic E. coli,
and the associated hemolytic uremic syndrome. Epidemiol Rev 13, 60–
98.
Hancock, D. D., Besser, T. E., Rice, D. H., Herriott, D. E. & Tarr, P. I.
(1997). A longitudinal study of Escherichia coli O157 in fourteen cattle
herds. Epidemiol Infect 118, 193–195.
R. J. Fernandez-Brando and others
858 Journal of Medical Microbiology 61
Karmali, M. A. (1989). Infection by verocytotoxin-producing
Escherichia coli. Clin Microbiol Rev 2, 15–38.
Karmali, M. A., Petric, M., Lim, C., Cheung, R. & Arbus, G. S. (1985).
Sensitive method for detecting low numbers of verotoxin-producing
Escherichia coli in mixed cultures by use of colony sweeps and
polymyxin extraction of verotoxin. J Clin Microbiol 22, 614–619.
Keepers, T. R., Psotka, M. A., Gross, L. K. & Obrig, T. G. (2006). A
murine model of HUS: Shiga toxin with lipopolysaccharide mimics
the renal damage and physiologic response of human disease. J Am
Soc Nephrol 17, 3404–3414.
Koitabashi, T., Vuddhakul, V., Radu, S., Morigaki, T., Asai, N.,
Nakaguchi, Y. & Nishibuchi, M. (2006). Genetic characterization of
Escherichia coli O157 : H7/2 strains carrying the stx2 gene but not
producing Shiga toxin 2. Microbiol Immunol 50, 135–148.
Leotta, G. A., Chinen, I., Epszteyn, S., Miliwebsky, E., Melamed, I. C.,
Motter, M., Ferrer, M., Marey, E. & Rivas, M. (2005). [Validation of a
multiplex PCR for detection of Shiga toxin-producing Escherichia
coli]. Rev Argent Microbiol 37, 1–10 (in Spanish).
Lindgren, S. W., Melton, A. R. & O’Brien, A. D. (1993). Virulence of
enterohemorrhagic Escherichia coli O91 : H21 clinical isolates in an
orally infected mouse model. Infect Immun 61, 3832–3842.
Linton, A. H., Al-Chalaby, Z. A. & Hinton, M. H. (1985). Natural
subclinical Salmonella infection in chickens: a potential model for
testing the effects of various procedures on Salmonella shedding. Vet
Rec 116, 361–364.
Lyte, M., Arulanandam, B. P. & Frank, C. D. (1996). Production of
Shiga-like toxins by Escherichia coli O157 : H7 can be influenced by
the neuroendocrine hormone norepinephrine. J Lab Clin Med 128,
392–398.
Merrell, D. S., Butler, S. M., Qadri, F., Dolganov, N. A., Alam, A.,
Cohen, M. B., Calderwood, S. B., Schoolnik, G. K. & Camilli, A.
(2002). Host-induced epidemic spread of the cholera bacterium.
Nature 417, 642–645.
Molyneux, G., Gibson, F. M., Gordon-Smith, E. C., Pilling, A. M., Liu,
K. C., Rizzo, S., Sulsh, S. & Turton, J. A. (2005). The haemotoxicity of
mitomycin in a repeat dose study in the female CD-1 mouse. Int J Exp
Pathol 86, 415–430.
Mühldorfer, I., Hacker, J., Keusch, G. T., Acheson, D. W., Tschäpe, H.,
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